Research Sample bioBank
Can’t find what you’re looking for? Contact us.
Or, need help ordering? 805.528.4341
Get Weekly Research Sample Updates in your Inbox:
Primary Biliary Cirrhosis (PBC) Clinical Research Samples
Discovery Life Sciences provides the highest quality Primary Biliary Cirrhosis (PBC) Clinical Research Samples and Residual Diagnostic Specimens from the Life Science Industry’s only convenient online, open access Biobank.
- All Primary Biliary Cirrhosis (PBC) Sample Orders are Packaged for Delivery within 24 Hours.
- All Specimens Ethically Obtained, De-Identified and provided with Highly Annotated Demographic and Clinical Data.
- Select from an HHS/OHRP Compliant Biorepository following ISBER/BBRB Guidelines.
- Packaged in Compliance with all UN Regulations (6.2) and U.S. DOT Hazmat regulations.
Buy | Product ID | Sample | Origin | Matrix | Vial (ml) | Quantity | Price | Age | Gender | Ethnicity | Storage Temp | Sample Date | Test 1 | Test Data 1 | Test 2 | Test Data 2 | Detail 2 | Test 3 | Test Data 3 | Detail 3 | Product Details | Price | Buy | Blood Type | Co-morbidities | Consent Status Date | Current Medications | Is Pregnant | Laboratory Results | Risk Group | Ever developed Jaundice | Liver Biopsy | Cirrhosis? | Ascites? | History of Renal Insufficiency? | Bilirubin | Initial Date of Disease Diagnosis | Cirrhosis | All Known Test Results Performed in Previous Six months |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| BBS0000-CY900356654081419DD | Primary Biliary Cirrhosis (PBC) | United States | Serum | 1.00 | 1.00 | $150.00 | 72 Y | Female | Non-Hispanic | <-70C | 14-Aug-19 | Clinical Diagnosis | Primary Biliary Cirrhosis (PBC) | Ultrasound | Increased echotexture of the liver is non-specific and may reflect fatty infiltration | 2012-03-28 | CT | Liver is unremarkable in appearance | 20-Jun-09 | $150.00 | Unknown | Hypothyroidism, Osteopenia, Anemia, Monoclonal paraproteinemia, Asymptomatic gallstones, Rheumatoid arthritis | 2019-08-14 | Levothyroxine, Benicar, Castia, Aspirin, Ocuvite, Os-Cal, Hydroxychloroquine sulfate, Pilocarpine HCl, Ursodiol, Meloxicam | False | ALT: 22 U/L | AST: 34 U/L | GGT: 74 U/L | Bilirubin (direct): 0.3 mg/dL | Bilirubin (total): 0.6 mg/dL | 1-Jul-2019 | | None | No | Yes in 2002 | Minimal portal lobular hepatitis, no evidence of fibrosis | No | No | No | |||||||
| BBS0000-CY900356655100419DD | Primary Biliary Cirrhosis (PBC) | United States | Serum | 1.00 | 1.00 | $150.00 | 69 Y | Female | Non-Hispanic | <-70C | 04-Oct-19 | Clinical Diagnosis | Primary Biliary Cirrhosis (PBC) | Ultrasound | 1.8 cm hepatic echogenic nodule, probable hemagioma | 2018-01-21 | MRI | No concerning liver lesions, Cirrhosis or scaarring not seen | 26-Feb-19 | $150.00 | Unknown | Diabetes mellitus, Hyperlipidemia | 2019-10-04 | Metformin, Glipizide, Ursodiol | False | ALT: 25 U/L | AST: 25 U/L | Bilirubin (total): 0.2 mg/dL | 19-Jul-2019 | Cholesterol: 194 mg/dL | Triglycerides: 45 mg/dL | HDL: 103 mg/dL | LDL: 82 mg/dL | 4-May-2019 | Hyperlipidemia, Diabetes | No | No | No | No | No | |||||||
| BBS0000-CY900356656071619DD | Primary Biliary Cirrhosis (PBC) | United States | Serum | 1.00 | 2.00 | $150.00 | 81 Y | Female | Non-Hispanic | <-70C | 16-Jul-19 | Clinical Diagnosis | Primary Biliary Cirrhosis (PBC) | $150.00 | Unknown | Hypertension, Arthritis, Thyroid disease, High cholesterol | 2019-07-16 | Enalapril, Lovastatin, Amlodipine besylate, Carvedilol, Levothyroxine, Trazodone | False | ALT: 37 U/L | AST: 38 U/L | Bilirubin (total): 0.9 mg/dL | 4-Feb-2019 | | Hyperlipidemia | No | No | No | No | No | |||||||||||||
| BBS0000-CY900400675010820DD | Primary Biliary Cirrhosis (PBC) | United States | Serum | 4.50 | 1.00 | $150.00 | 71 Y | Female | Non-Hispanic | <-70C | 08-Jan-20 | Clinical Diagnosis | Primary Biliary Cirrhosis (PBC) | Ultrasound | Coarsened hepatic echotexture correlate for chronic liver disease | 12-Nov-19 | CT Scan | Liver without suspicious focal lesion | 20-Nov-18 | $150.00 | Unknown | Thyroid disease | 2020-01-08 | Levothyroxine sodium, Ursodiol | False | ALT: 19 U/L AST: 28 U/L Bilirubin (total): 0.4 mg/dL 30-Dec-2019 | None | No | No | No | No | No | |||||||
| EDP0000-AI900385849030920DD | Primary Biliary Cirrhosis (PBC) | United States | K2 EDTA Plasma | 1.60 | 1.00 | $75.00 | 56 Y | Female | Non-Hispanic | <-70C | 09-Mar-20 | Diagnosis | Primary Biliary Cirrhosis (PBC) | Abbott Architect | Kinetic W/O Pyridoxal Phosphate | 9 U/L | ALT | Abbott Architect | Kinetic W/O Pyridoxal Phosphate | 11 U/L | AST | $75.00 | Unknown | 0.7 | |||||||||||||||||
| EDP0000-CY900085553061219DD | Primary Biliary Cirrhosis (PBC) | United States | K2 EDTA Plasma | 1.00 | 1.00 | $150.00 | 72 Y | Female | Non-Hispanic | <-70C | 12-Jun-19 | Clinical Diagnosis | PBC | X-ray | Ultrasound | Nodular contour consistent with cirrhosis | Cirrhotic hepatic morphology without focal lesion | 5-July-2016 | 9-Aug-2018 | CT | No biliary ductal dilation. Similar mild atrophy of right hepatic lobe | 28-Nov-17 | $150.00 | Unknown | Hypertension, Thyroid disease, Atrial fibrillation | Atorvastatin, Digoxin, Montelukast, Spironolactone, Levoxyl, Letrozole, Ursodiol, Fosamax, Metoprolol succinate | No | Yes | Chronic hepatitis compatible with PBC Stage 1 Fibrosis 27-Aug-02 | 27-Aug-02 | Yes | CT scan 15-Nov | ||||||||||||
| EDP0000-CY900356654081419DD | Primary Biliary Cirrhosis (PBC) | United States | K2 EDTA Plasma | 1.00 | 8.00 | $150.00 | 72 Y | Female | Non-Hispanic | <-70C | 14-Aug-19 | Clinical Diagnosis | Primary Biliary Cirrhosis (PBC) | Ultrasound | Increased echotexture of the liver is non-specific and may reflect fatty infiltration | 2012-03-28 | CT | Liver is unremarkable in appearance | 20-Jun-09 | $150.00 | Unknown | Hypothyroidism, Osteopenia, Anemia, Monoclonal paraproteinemia, Asymptomatic gallstones, Rheumatoid arthritis | 2019-08-14 | Levothyroxine, Benicar, Castia, Aspirin, Ocuvite, Os-Cal, Hydroxychloroquine sulfate, Pilocarpine HCl, Ursodiol, Meloxicam | False | ALT: 22 U/L | AST: 34 U/L | GGT: 74 U/L | Bilirubin (direct): 0.3 mg/dL | Bilirubin (total): 0.6 mg/dL | 1-Jul-2019 | | None | No | Yes in 2002 | Minimal portal lobular hepatitis, no evidence of fibrosis | No | No | No | |||||||
| EDP0000-CY900356656071619DD | Primary Biliary Cirrhosis (PBC) | United States | K2 EDTA Plasma | 1.00 | 6.00 | $150.00 | 81 Y | Female | Non-Hispanic | <-70C | 16-Jul-19 | Clinical Diagnosis | Primary Biliary Cirrhosis (PBC) | $150.00 | Unknown | Hypertension, Arthritis, Thyroid disease, High cholesterol | 2019-07-16 | Enalapril, Lovastatin, Amlodipine besylate, Carvedilol, Levothyroxine, Trazodone | False | ALT: 37 U/L | AST: 38 U/L | Bilirubin (total): 0.9 mg/dL | 4-Feb-2019 | | Hyperlipidemia | No | No | No | No | No | |||||||||||||
| EDP0000-CY900356658071119DD | Primary Biliary Cirrhosis (PBC) | United States | K2 EDTA Plasma | 4.00 | 2.00 | $150.00 | 59 Y | Female | Non-Hispanic | <-70C | 11-Jul-19 | Clinical Diagnosis | Primary Biliary Cirrhosis (PBC) | Ultrasound | Heterogeneous liver | 2018-05-18 | MRI | Mild to moderate Cirrhosis | 5-Jun-18 | $150.00 | Unknown | None | 2019-07-11 | Ursodiol | False | ALT: 19 U/L | AST: 23 U/L | Bilirubin (total): 0.5 mg/dL | Triglycerides: 70 mg/dL | HDL: 73 mg/dL | LDL: 102 mg/dL | 12-Feb-2019 | None | No | Yes | PBC stage 2 Fibrosis 9-Jul-2018 | Yes | MRI 5-Jun-18 | No | No | |||||||
| EDP0000-CY900400675010820DD | Primary Biliary Cirrhosis (PBC) | United States | K2 EDTA Plasma | 5.00 | 2.00 | $150.00 | 71 Y | Female | Non-Hispanic | <-70C | 08-Jan-20 | Clinical Diagnosis | Primary Biliary Cirrhosis (PBC) | Ultrasound | Coarsened hepatic echotexture correlate for chronic liver disease | 12-Nov-19 | CT Scan | Liver without suspicious focal lesion | 20-Nov-18 | $150.00 | Unknown | Thyroid disease | 2020-01-08 | Levothyroxine sodium, Ursodiol | False | ALT: 19 U/L AST: 28 U/L Bilirubin (total): 0.4 mg/dL 30-Dec-2019 | None | No | No | No | No | No | |||||||
| EDP0000-FD900043137031618DD | Primary Biliary Cirrhosis (PBC) | K2 EDTA Plasma | 1.00 | 2.00 | $150.00 | 56 Y | Female | Non-Hispanic | <-70C | 16-Mar-18 | Clinical Diagnosis | Primary Biliary Cirrhosis | Ultrasound | Normal Liver | 7-Jul-17 | $150.00 | Unknown | None | Ursodial | No | No | 12-May-17 | No | ALT: 28 U/L | AST: 23 U/L | GGT: 72 U/L | Bilirubin (direct): 4 umol/L | Bilirubin (total): 12 umol/L 2-Feb-2018 |
Keep in mind that all the samples comprised in the Research Sample Biobank represent only a small number of the clinical research specimens available through our Discovery Partners™ clinical research programs. If you can’t find the specific sample type, specimen or biofluids you are looking for please make sure to call our client services group at 805.528.4341 - and ask how we can help support your project from resources available at active clinical sites.
Please read carefully before purchasing:
Clinical specimens for research use only.
Transmissible Infectious Risk! May be HIV, HBV and HCV REACTIVE or of unknown infectious agent test status. Materials provided are derived from human blood, tissue and other bio-fluids. Handle all samples as if capable of transmitting infectious agents. Practice good laboratory technique and dispose of in properly marked medical waste.
If you need help searching for a LARGER SAMPLE SET with specific data elements, please contact our Client Services group who can format Excel spreadsheets for a comprehensive review of all available samples: USA (805) 528-4341
These products are supplied without warranty for suitability for specific applications or analytical determinations.
Specimens and data will be may be used for general biomarker research, assay and instrument validation purposes only. All Research products identified as “Diagnostic Remnant Samples” are human biological materials leftover from routine laboratory analysis and are de-identified (coded) to protect subject confidentiality. Under OHRP definition 45 CFR 46.102(f) these coded specimens are not considered subjects for Human research requiring informed consent. Specimens cannot be used for whole genomic sequencing of genetic material. Research products designated as “Clinical Research Samples” by “type” are obtained from IRB approved research study protocols with informed consent obtained from each subject enrolled. Specimens cannot be used for whole genomic sequencing of genetic material.